December 2022 – Texas Dermatology

Treat Your Alopecia Areata with Olumiant

Studies conducted by Texas dermatology help to aid in FDA-approval of treatment for Alopecia Areata: Olumiant! Read more in our latest blog!

Although you may not be familiar with the name, alopecia areata is a very common autoimmune disease affecting almost 300,000 people in the U.S. annually. Alopecia areata causes the body to attack its own hair follicles, thus leading to hair loss and bald spots. This phenomenon usually occurs on the scalp and face but is … Read more

Opzelura: A Breakthrough Topical in Dermatology

Opzelura: An FDS-approved breakthrough eczema treatment. Read our blog to learn more about opzelura and the trials Texas Dermatology was involved in to help it get approved.

Here at Texas Dermatology, one of our favorite ways to contribute to the medical field is by conducting clinical trials meant to aid the advancement of medicine. What makes this more exciting is when a drug we’ve personally tested is approved by the Food and Drug Administration and made accessible to the public. A great … Read more